Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3

[1]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[2]  Jennifer Mulle,et al.  A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci , 2012, PLoS genetics.

[3]  D. Swallow,et al.  Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. , 2011, American journal of human genetics.

[4]  Judy H Cho,et al.  Improved risk prediction for Crohn's disease with a multi-locus approach. , 2011, Human molecular genetics.

[5]  Alexander Gusev,et al.  DASH: a method for identical-by-descent haplotype mapping uncovers association with recent variation. , 2011, American journal of human genetics.

[6]  E. Zeggini,et al.  Synthetic Associations Are Unlikely to Account for Many Common Disease Genome-Wide Association Signals , 2011, PLoS biology.

[7]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[8]  R. Desnick,et al.  Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study , 2011, BMC Medical Genetics.

[9]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[10]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[11]  S. Warren,et al.  Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population , 2010, Proceedings of the National Academy of Sciences.

[12]  Itsik Pe'er,et al.  Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. , 2010, American journal of human genetics.

[13]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[14]  R. Elkon,et al.  BRD7 is a candidate tumour suppressor gene required for p53 function , 2010, Nature Cell Biology.

[15]  David B. Goldstein,et al.  Rare Variants Create Synthetic Genome-Wide Associations , 2010, PLoS biology.

[16]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[17]  Alexander Gusev,et al.  Whole population, genome-wide mapping of hidden relatedness. , 2009, Genome research.

[18]  F. Cambien,et al.  Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells , 2008, BMC Genomics.

[19]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[20]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[21]  S. Brant,et al.  A Population-Based Case-Control Study of CARD15 and Other Risk Factors in Crohn's Disease and Ulcerative Colitis , 2007, The American Journal of Gastroenterology.

[22]  C. Eun.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. , 2007 .

[23]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[24]  M. Cheang,et al.  A Population-Based Case Control Study of Potential Risk Factors for IBD , 2006, The American Journal of Gastroenterology.

[25]  R. Eliakim,et al.  The Relation Between NOD2/CARD15 Mutations and the Prevalence and Phenotypic Heterogeneity of Crohn’s Disease: Lessons from the Israeli Arab Crohn’s Disease Cohort , 2005, Digestive Diseases and Sciences.

[26]  J. Ioannidis,et al.  Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis , 2004, The American Journal of Gastroenterology.

[27]  N. Risch,et al.  Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. , 2004, American journal of human genetics.

[28]  M. Silverberg,et al.  CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease , 2004, American Journal of Gastroenterology.

[29]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[30]  S. Targan,et al.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. , 2003, American journal of human genetics.

[31]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[32]  Judy H. Cho,et al.  Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. , 2003, Gastroenterology.

[33]  J. Silver,et al.  Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population , 2002, American Journal of Gastroenterology.

[34]  H. Ostrer.  A genetic profile of contemporary Jewish populations , 2001, Nature Reviews Genetics.

[35]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[36]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[37]  H. Smart,et al.  Crohn's disease in Jewish people--an epidemiological study in south-east Wales. , 1986, Digestion.